Stockreport

Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404

PROGENICS PHARMACEUTICALS  (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com
PDF -Meets Co-Primary Endpoint of Specificity; 1404 Successfully Identifies Patients Without Clinically Significant Prostate Cancer--Co-Primary Endpoint of Sensitivity to Id [Read more]